Free Consultation

What Happens to Your Pharmacy on November 28 If You’re Not Ready

The day after the DSCSA deadline should not be the day your pharmacy starts asking where the records are.

November 27, 2026, is the date many small dispensers are watching.

Update: “FDA is issuing exemptions from certain requirements of section 582 of the FD&C Act to small dispensers (e.g. pharmacies), and where applicable their trading partners, until November 27, 2027.”

But pharmacies should also think about the next day.

What happens on November 28 if your pharmacy is not ready?

The answer is not that the doors automatically close.

The answer is more practical, and more uncomfortable.

Your pharmacy may be expected to operate in a DSCSA environment where excuses are harder to defend, records are harder to rebuild, and gaps are harder to explain.

As Jim Shaver, Managing Director at Advasur, developer behind PRS DSCSA 360, puts it: “November 28 is not the day DSCSA suddenly matters. It is the day being unprepared becomes much harder to explain.”

That is why pharmacies should prepare before the deadline arrives.

November 28 does not give your pharmacy a reset button.

The day after the deadline, your pharmacy will still be busy.

Patients will still need prescriptions.

Deliveries will still arrive.

Suppliers will still send product.

Staff will still be answering phones, receiving orders, filling prescriptions, and solving problems.

The difference is that your pharmacy should already have its DSCSA process in place.

That means knowing:

  • Which suppliers are active?
  • Whether suppliers are Authorized Trading Partners
  • Where transaction data is stored
  • Whether EPCIS, EDI 856, ASN, portal, or other records are being received.
  • How missing data is documented.
  • How reconciliation activity is handled
  • How exceptions are tracked
  • How suspect product concerns are escalated.
  • How records are retained and retrieved

If those pieces are not ready, November 28 may feel less like a deadline passing and more like a problem beginning.

Supplier gaps may become harder to ignore.

Supplier setup is one of the biggest reasons not to wait.

Some suppliers may be ready.

Some may require follow-up.

Some may send EPCIS.

Some may still rely on EDI 856, ASN records, portals, email, or another process.

Some data may be missing, delayed, incomplete, or hard to match.

If your pharmacy has not reviewed supplier connections before the deadline, those issues do not disappear on November 28.

They become more urgent.

A pharmacy that starts early has time to find supplier gaps and work through them calmly.

A pharmacy that waits may be chasing answers while also trying to keep daily operations moving.

Missing records become harder to defend.

One of the biggest DSCSA risks is not knowing where records are.

If transaction data is scattered across supplier portals, emails, downloads, spreadsheets, shared folders, and staff memory, the pharmacy may struggle to respond when someone asks for proof.

On November 28, the pharmacy should not be asking:

Who knows where that file is?

It should be able to say:

Here is the record. Here is the supplier. Here is the shipment. Here is what happened.

That is the difference between having records somewhere and having a process.

Staff confusion becomes a real operational problem.

DSCSA cannot depend on one person.

If only one employee knows where records are stored, how to retrieve them, or what to do when data is missing, the process is fragile.

After the deadline, staff should already know:

  • Where DSCSA records are located
  • How to retrieve records
  • What to do when data is missing
  • How reconciliation activity works
  • When to document an exception
  • When to escalate a suspect product concern

Training should not happen after the pharmacy realizes it needed training.

The middle of deadline pressure is the wrong time to explain the basics for the first time.

Product questions may take longer to answer.

DSCSA is about more than compliance paperwork.

It supports the ability to answer product questions.

If there is a recall, supplier question, manufacturer request, state board inquiry, suspect product concern, or internal review, your pharmacy may need to know:

  • Where the product came from
  • Which supplier sent it?
  • Which shipment was involved?
  • What transaction data was received?
  • Whether anything was missing or delayed
  • What action was taken?
  • Whether records can be retrieved

If your DSCSA process is not ready, those questions can take longer to answer and may be harder to document.

That is not a position any pharmacy wants to be in.

The small dispenser exemption does not erase existing responsibilities.

Qualifying small dispensers received additional time until November 27, 2026, for certain enhanced DSCSA requirements.

But that does not mean all DSCSA responsibilities were paused.

Small dispensers still need to know their suppliers, understand where product tracing information is stored, access records when needed, and maintain appropriate procedures for suspect and illegitimate product concerns.

The exemption gives time.

It does not erase the work.

November 28 is what happens when that extra time has been spent.

What being ready should look like

By the time the deadline arrives, your pharmacy should be able to answer practical questions:

  • Do we know our active suppliers?
  • Do we know how transaction data is being received?
  • Are supplier records connected to shipments?
  • Can trained staff retrieve records?
  • Do we have a missing-data process?
  • Can we document reconciliation activity?
  • Can we track exceptions?
  • Do staff know what to do with suspect product concerns?
  • Are records retained for six years?
  • Can we show what happened when someone asks?

If the answer is no, the pharmacy should start now.

How PRS DSCSA 360 helps before November 28

PRS DSCSA 360 helps pharmacies turn DSCSA preparation into a practical process before the deadline becomes pressure.

The platform supports:

  • Transaction data receipt and retention
  • EPCIS and EDI 856 record management
  • Supplier and shipment visibility
  • Authorized Trading Partner support
  • Reconciliation activity
  • Missing-data workflows
  • Exception documentation
  • Suspect product procedures
  • Staff training support
  • Six-year record retention
  • Record retrieval when someone asks.

PRS DSCSA 360 was built by pharmacists, for pharmacists, and shaped by more than a decade of focused DSCSA experience.

Just as important, PRS DSCSA 360 includes white-glove support from people who understand pharmacy operations.

That means your pharmacy does not have to wait until November 28 to discover what should have been fixed earlier.

Do not make November 28 the first day of your DSCSA project.

The best time to find DSCSA gaps is before the deadline.

Before supplier issues become urgent.

Before staff confusion becomes operational.

Before missing records become a scramble.

Before product questions require answers your pharmacy cannot easily show.

Waiting may feel easier today.

It will not feel easier on November 28.

Schedule your PRS DSCSA 360 readiness review

If your pharmacy is not ready for DSCSA, now is the time to act.

In a 30-minute PRS DSCSA 360 DSCSA Readiness Review, we can walk through your current process and help identify what needs to happen before November 27, 2026.

We can review:

  • Supplier setup
  • Transaction data receipt and retention
  • EPCIS and EDI 856 readiness
  • Missing-data workflows
  • Reconciliation activity
  • Exception documentation
  • Suspect product procedures
  • Staff training
  • Six-year record retention
  • Record retrieval

No pressure.

No scare tactics.

Just a practical look at how to get your pharmacy ready before November 28 turns gaps into problems.

Schedule your 30-minute PRS DSCSA 360 DSCSA Readiness Review today:

prsrx.com/compliance/dscsa360/

November 28 should be a normal pharmacy day. PRS DSCSA 360 helps make sure DSCSA is not the reason it becomes something else.

Update: “FDA is issuing exemptions from certain requirements of section 582 of the FD&C Act to small dispensers (e.g. pharmacies), and where applicable their trading partners, until November 27, 2027.”